United States · Platforms & data · MarketBeat
Zacks Research Cuts Earnings Estimates for Gilead Sciences

Detailed summary
Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Investment analysts at Zacks Research reduced their FY2026 earnings estimates for Gilead Sciences in a research report issued to clients and investors on Thursday, November 12th. Zacks Research analyst Team now expects that the biopharmaceutical co
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)


